Market Currents
Abbott Labs (ABT) completes the separation of AbbVie (ABBV), its R&D-based pharmaceuticals...
-
Wednesday, January 2, 8:55 AM ETAbbott Labs (ABT) completes the separation of AbbVie (ABBV), its R&D-based pharmaceuticals business that will start trading on the NYSE today. Wells Fargo maintains an "Outperform" rating on Abbott's shares, citing the company's above-average growth outlook and opportunities to significantly increase its margin. Wells Fargo sets Abbott a price target of $33-$34; its shares are $32.25 premarket.(PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
